Uzair Ghori, MD
Pulmonary Disease · Milwaukee, WINPI 1750721346
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 83.7% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $13,947, 8.4 times the $1,654 reported in 2019. Among pulmonary disease clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $381.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$27K
- Boston Scientific$3K
- Pulmonx Corporation$2K
- AstraZeneca$208
- Pinnacle Biologics, Inc$198
- Johnson & Johnson$138
- plus $335 from 6 others
Across 2 payments — averaging $15,023 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$30K
What the payments were for
- Consulting fees$2001%
- Speaking & faculty fees$8,50026%
- Travel & lodging$5,61917%
- Food & beverage$3,56711%
- Education$14,50045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 37 | $27,115 |
| Boston Scientific | 19 | $2,540 |
| Pulmonx Corporation | 15 | $1,851 |
| AstraZeneca | 2 | $208 |
| Pinnacle Biologics, Inc | 3 | $198 |
| Johnson & Johnson | 1 | $138 |
| GSK | 2 | $136 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Galvanize Therapeutics, Inc | 1 | $35 |
| Boehringer Ingelheim | 2 | $26 |
| Insmed, Inc. | 1 | $12 |
| Veran Medical Technologies, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$23,492
- ION$3,000
- ZEPHYR ENDOBRONCHIAL VALVE$1,512
- GENERAL - THERAPIES$1,194
- CHARTIS CATHETER$616
- ZEPHYR DELIVERY CATHETER$616
- PULMONX CHARTIS TABLET CONSOLE$616
- ULTRAFLEX$462
- GENERAL PULMONARY$276
- Monarch Platform$138
- NUCALA$124
- DUPIXENT$122
- LOKELMA$121
How this compares
$32,386 in reported general payments places this provider in the 90th percentile of 247 pulmonary disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Milwaukee
- Jonathan KurmanMilwaukee$803K
- Mouhammed RihawiMilwaukee$713K
- Kurt HuMilwaukee$55K
- Julie BillerMilwaukee$52K
- Mark BarashMilwaukee$52K
- Rahul NanchalMilwaukee$42K
- Steven LehMilwaukee$40K
- Ali MusaniMilwaukee$38K
- Michael KatzoffMilwaukee$37K
- Jayshil PatelMilwaukee$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.